Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan D Parsons

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Analytical Biochemistry|November 28, 2006
A high-throughput method for fitting dose-response curves using Microsoft ExcelJonathan D Parsons
Antimicrobial Agents and Chemotherapy|April 24, 2004
Crystal structures of Escherichia coli topoisomerase IV ParE subunit (24 and 43 kilodaltons): a single residue dictates differences in novobiocin potency against topoisomerase IV and DNA gyraseSteven Bellon, Jonathan D Parsons, Yunyi Wei, et al.
Antimicrobial Agents and Chemotherapy|March 30, 2006
In vitro characterization of the antibacterial spectrum of novel bacterial type II topoisomerase inhibitors of the aminobenzimidazole classNagraj Mani, Christian H Gross, Jonathan D Parsons, et al.
Antimicrobial Agents and Chemotherapy|February 27, 2003
Active-site residues of Escherichia coli DNA gyrase required in coupling ATP hydrolysis to DNA supercoiling and amino acid substitutions leading to novobiocin resistanceChristian H Gross, Jonathan D Parsons, Trudy H Grossman, et al.
Antimicrobial Agents and Chemotherapy|November 23, 2006
Dual targeting of GyrB and ParE by a novel aminobenzimidazole class of antibacterial compoundsTrudy H Grossman, Douglas J Bartels, Steve Mullin, et al.
Bioorganic & Medicinal Chemistry Letters|April 2, 2010
Discovery of pyrazolthiazoles as novel and potent inhibitors of bacterial gyraseSteven M Ronkin, Michael Badia, Steve Bellon, et al.
Journal of Medicinal Chemistry|August 12, 2008
Novel dual-targeting benzimidazole urea inhibitors of DNA gyrase and topoisomerase IV possessing potent antibacterial activity: intelligent design and evolution through the judicious use of structure-guided design and structure-activity relationshipsPaul S Charifson, Anne-Laure Grillot, Trudy H Grossman, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Analytical Biochemistry|November 28, 2006
A high-throughput method for fitting dose-response curves using Microsoft ExcelJonathan D Parsons
Antimicrobial Agents and Chemotherapy|April 24, 2004
Crystal structures of Escherichia coli topoisomerase IV ParE subunit (24 and 43 kilodaltons): a single residue dictates differences in novobiocin potency against topoisomerase IV and DNA gyraseSteven Bellon, Jonathan D Parsons, Yunyi Wei, et al.
Antimicrobial Agents and Chemotherapy|March 30, 2006
In vitro characterization of the antibacterial spectrum of novel bacterial type II topoisomerase inhibitors of the aminobenzimidazole classNagraj Mani, Christian H Gross, Jonathan D Parsons, et al.
Antimicrobial Agents and Chemotherapy|February 27, 2003
Active-site residues of Escherichia coli DNA gyrase required in coupling ATP hydrolysis to DNA supercoiling and amino acid substitutions leading to novobiocin resistanceChristian H Gross, Jonathan D Parsons, Trudy H Grossman, et al.
Antimicrobial Agents and Chemotherapy|November 23, 2006
Dual targeting of GyrB and ParE by a novel aminobenzimidazole class of antibacterial compoundsTrudy H Grossman, Douglas J Bartels, Steve Mullin, et al.
Bioorganic & Medicinal Chemistry Letters|April 2, 2010
Discovery of pyrazolthiazoles as novel and potent inhibitors of bacterial gyraseSteven M Ronkin, Michael Badia, Steve Bellon, et al.
Journal of Medicinal Chemistry|August 12, 2008
Novel dual-targeting benzimidazole urea inhibitors of DNA gyrase and topoisomerase IV possessing potent antibacterial activity: intelligent design and evolution through the judicious use of structure-guided design and structure-activity relationshipsPaul S Charifson, Anne-Laure Grillot, Trudy H Grossman, et al.
Pageof 1